Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation--focus on aspergillosis
- PMID: 19375636
- DOI: 10.1016/j.ccm.2009.03.001
Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation--focus on aspergillosis
Abstract
Invasive fungal infections (IFIs) represent a major complication in recipients of hematopoietic stem cell transplantation and solid-organ transplantation. The incidence of IFIs in transplant recipients has increased over the past 20 years, and these infections continue to be associated with high morbidity and mortality. This article reviews the important concepts guiding the management of IFIs in transplant recipients, including epidemiologic trends, new risk factors, and a timetable of infections, pathogens, therapy, and prevention of these infections. An emphasis is given to invasive aspergillosis.
Similar articles
-
Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients.Br J Haematol. 2007 Nov;139(4):519-31. doi: 10.1111/j.1365-2141.2007.06812.x. Br J Haematol. 2007. PMID: 17979942 Review.
-
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).Clin Infect Dis. 2010 Apr 15;50(8):1101-11. doi: 10.1086/651262. Clin Infect Dis. 2010. PMID: 20218876
-
Aspergillus pulmonary infections in transplant recipients.Clin Chest Med. 2005 Dec;26(4):661-74, vii. doi: 10.1016/j.ccm.2005.06.007. Clin Chest Med. 2005. PMID: 16263404 Review.
-
[Fungal infections in transplantation patients].Recenti Prog Med. 2003 Nov;94(11):516-28. Recenti Prog Med. 2003. PMID: 14679922 Review. Italian.
-
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.Clin Infect Dis. 2007 Nov 1;45(9):1161-70. doi: 10.1086/522189. Epub 2007 Sep 26. Clin Infect Dis. 2007. PMID: 17918077
Cited by
-
Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs.PLoS Pathog. 2010 Jun 3;6(6):e1000939. doi: 10.1371/journal.ppat.1000939. PLoS Pathog. 2010. PMID: 20532216 Free PMC article.
-
Clinical Characteristics and Prognostic Risk Factors of Patients With Proven Invasive Pulmonary Aspergillosis: A Single-Institution Retrospective Study.Front Med (Lausanne). 2021 Dec 23;8:756237. doi: 10.3389/fmed.2021.756237. eCollection 2021. Front Med (Lausanne). 2021. PMID: 35004724 Free PMC article.
-
Epidemiology of Aspergillosis Diagnoses in the U.S. using a National EHR Database, 2013-2023.medRxiv [Preprint]. 2025 Jun 23:2025.06.19.25329882. doi: 10.1101/2025.06.19.25329882. medRxiv. 2025. PMID: 40666327 Free PMC article. Preprint.
-
Benzothieno[3,2-b]quinolinium and 3-(phenylthio)quinolinium compounds: Synthesis and evaluation against opportunistic fungal pathogens.Bioorg Med Chem. 2011 Jan 1;19(1):458-70. doi: 10.1016/j.bmc.2010.11.008. Epub 2010 Nov 10. Bioorg Med Chem. 2011. PMID: 21134759 Free PMC article.
-
A Rare Case of Invasive Aspergillosis of the Pituitary Gland in a Young Immunocompetent Host: Diagnostic Pitfalls and Postoperative Complications.Cureus. 2024 Jul 26;16(7):e65470. doi: 10.7759/cureus.65470. eCollection 2024 Jul. Cureus. 2024. PMID: 39188442 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous